Status:
COMPLETED
Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients
Lead Sponsor:
University Hospital Muenster
Collaborating Sponsors:
Amgen
Conditions:
Kidney Transplantation
Anemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Correction of anaemia in renal transplant recipients by parenteral application of recombinant erythropoietin and if necessary iron will improve large artery function (endothelial function and elastici...
Detailed Description
The value of anaemia therapy with recombinant erythropoietin and iron for improvement of cardiovascular outcome has been clearly demonstrated in dialysis patients and is standard of care. In this pati...
Eligibility Criteria
Inclusion
- kidney transplant recipient stable kidney function Hb between 10mg/ml and 10.5mg/ml
Exclusion
- acute rejection Hb above 12.0mg/dl
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00204334
Start Date
June 1 2005
End Date
January 1 2010
Last Update
January 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UKM
Münster, North Rhine-Westphalia, Germany, 48149